Cargando…
The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003420/ https://www.ncbi.nlm.nih.gov/pubmed/24769644 http://dx.doi.org/10.1038/bcj.2014.26 |
| _version_ | 1782313846110683136 |
|---|---|
| author | Masurekar, A Fong, C Hussein, A Revesz, T Hoogerbrugge, P M Love, S Ciria, C Parker, C Krishnan, S Saha, V |
| author_facet | Masurekar, A Fong, C Hussein, A Revesz, T Hoogerbrugge, P M Love, S Ciria, C Parker, C Krishnan, S Saha, V |
| author_sort | Masurekar, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4003420 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40034202014-04-29 The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial Masurekar, A Fong, C Hussein, A Revesz, T Hoogerbrugge, P M Love, S Ciria, C Parker, C Krishnan, S Saha, V Blood Cancer J Letter to the Editor Nature Publishing Group 2014-04 2014-04-25 /pmc/articles/PMC4003420/ /pubmed/24769644 http://dx.doi.org/10.1038/bcj.2014.26 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Letter to the Editor Masurekar, A Fong, C Hussein, A Revesz, T Hoogerbrugge, P M Love, S Ciria, C Parker, C Krishnan, S Saha, V The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial |
| title | The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial |
| title_full | The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial |
| title_fullStr | The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial |
| title_full_unstemmed | The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial |
| title_short | The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial |
| title_sort | optimal use of peg-asparaginase in relapsed all—lessons from the allr3 clinical trial |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003420/ https://www.ncbi.nlm.nih.gov/pubmed/24769644 http://dx.doi.org/10.1038/bcj.2014.26 |
| work_keys_str_mv | AT masurekara theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT fongc theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT husseina theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT reveszt theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT hoogerbruggepm theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT loves theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT ciriac theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT parkerc theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT krishnans theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT sahav theoptimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT masurekara optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT fongc optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT husseina optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT reveszt optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT hoogerbruggepm optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT loves optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT ciriac optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT parkerc optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT krishnans optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial AT sahav optimaluseofpegasparaginaseinrelapsedalllessonsfromtheallr3clinicaltrial |